DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Diener HC, Dodick DW, Aurora SK et al.
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Cephalalgia 2010;
30: 804-814
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.